Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10906985 Targeted engineered interferon and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Nikolai Kley0

Jan Tavernier0

Lennart Zabeau0

Date of Patent

February 2, 2021

0

Patent Application Number

164831090

Date Filed

February 5, 2018

0

Patent Citations

US Patent 10407480 Targeted modified TNF family members

US Patent 10640542 Fusokines involving cytokines with strongly reduced receptor binding affinities

US Patent 10034919 Targeted human-interferon fusion proteins

0

US Patent 10035835 Targeted modified TNF family members

US Patent 10072059 Targeting of human interferon antagonists

Patent Citations Received

US Patent 11753463 Therapeutic targeting of non-cellular structures

Patent Primary Examiner

0

Patent abstract

The present invention relates, in part, to chimeric proteins comprising consensus interferon, or a variant thereof, and their use as therapeutic agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10906985 Targeted engineered interferon and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool